Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.

Abstract excerpt

Bronchiectasis is characterised by pathological dilation of the airways. More specifically, the radiographic demonstration of airway enlargement is the common feature of a heterogeneous set of conditions and clinical presentations. No approved therapies exist for the condition other than for bronchiectasis caused by cystic fibrosis. The heterogeneity of bronchiectasis is a major challenge in clinical practice and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autoimmune Diseases
• Share to Bronchiectasis
• Share to Cystic Fibrosis